Printer Friendly
The Free Library
19,588,385 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Alpha-lipoic acid for diabetic neuropathy.


Four hundred forty-three patients with chronic painful neuropathy neuropathy

Disorder of the peripheral nervous system. It may be genetic or acquired, progress quickly or slowly, involve motor, sensory, and/or autonomic (see autonomic nervous system) nerves, and affect only certain nerves or all of them.
 were treated with 600 mg per day of alphalipoic acid (ALA) for a mean period of five years. ALA was then stopped, and 293 patients were switched to gabapentin (600-2400 mg per day), while 150 patients remained untreated because they had no current symptoms. In the untreated group, 110 patients (73%) developed neuropathic neuropathic /neu·ro·path·ic/ (-path´ik) pertaining to or characterized by neuropathy.

neuropathic

pertaining to disease of the nervous system.
 symptoms as soon as two weeks after the end of treatment with ALA.

Comment: ALA has been reported to decrease oxidative stress oxidative stress,
n an imbalance of the prooxidant antioxidant ratio in which too few antioxidants are produced or ingested or too many oxidizing agents are produced.
 and to prevent glycosylation of proteins (an early step in the formation of advanced glycation end products). Treatment with ALA has also been found to improve microcirculation microcirculation /mi·cro·cir·cu·la·tion/ (-sir?ku-la´shun) the flow of blood through the fine vessels (arterioles, capillaries, and venules).microcirculato´ry

mi·cro·cir·cu·la·tion
n.
 in patients with diabetic neuropathy Diabetic Neuropathy Definition

Diabetic neuropathy is a nerve disorder caused by diabetes mellitus. Diabetic neuropathy may be diffuse, affecting several parts of the body, or focal, affecting a specific nerve and part of the body.
. Each of these effects of ALA would be expected to be of value for the prevention or treatment of diabetic neuropathy. Numerous clinical trials have found that ALA decreases symptoms in patients with diabetic neuropathy, but these trials have generally been short term (three weeks to four months. The results of the present study suggest that the beneficial effects of ALA persist for up to five years with continued treatment.

Ruessmann HJ. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics Analgesics Definition

Analgesics are medicines that relieve pain.
Purpose

Analgesics are those drugs that mainly provide pain relief.
 in painful diabetic neuropathy: a real-world study in outpatients. J Diabetes Complicat. 2009;23:174-177.

by Alan R. Gaby, MD

drgaby@earthlink.net
COPYRIGHT 2009 The Townsend Letter Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Literature Review & Commentary
Author:Gaby, Alan R.
Publication:Townsend Letter
Article Type:Brief article
Geographic Code:1USA
Date:Nov 1, 2009
Words:222
Previous Article:Vitamin K prevents coronary artery calcification.
Next Article:Food additives harmful for kidney patients.
Topics:



Related Articles
Add lidocaine patch to gabapentin for pain relief. (Somnolence is Most Common Adverse Event).
Painful diabetic peripheral neuropathy relieved with use of oral topiramate. (Case Report).
Early screening needed to detect diabetic neuropathy.
Alpha-lipoic acid improves diabetic neuropathy.
A multitude of metabolic health benefits.
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Vitamin D for diabetic neuropathy.
Alpha-lipoic acid reduces triglycerides in model of obesity/diabetes.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles